August 7, 2019 Re : Management Discussion and Analysis for Q2/2019 To : Director and Manager of the Stock Exchange of Thailand Revenue from sales and rendering of services L&E’s consolidated revenue

May 12, 2018 Subject : Management Discussion and Analysis for quarter ended March 31, 2018 Attention : President The Stock Exchange of Thailand 1. Operating Performance . Revenues (Thousands Baht

Microsoft Word - el285e Date : August 14, 2018 Subject : Management Discussion and Analysis for the Quarter 2/2018 To : Managing Director The Stock Exchange of Thailand Kuang Pei San Food Products

(Translation) Ref.No.LEE 04/2020 14 May, 2020 Subject : Management Discussion and Analysis for the first quarter ended March 31, 2020 To : President of The Stock Exchange of Thailand We submit

  Management Discussion and Analysis, Q1/2018 Page 1/4 JMT

. DOD017/2562 May 8, 2019 Re: Management’s Discussion and Analysis (MD&A) of the Consolidated Financial Results for Quarter 1 of 2019 To: The President The Stock Exchange of Thailand DOD Biotech Public

/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited

Microsoft Word - ACE MDA Q1 24 - EN V.Format Edited 090524 1 No. ACE-ACC-2/2024 13 May 2024 Subject Management Discussion and Analysis for the period ended 31 March 2024 To President The Stock

 for 1Q20 decreased by 74.83% to THB 11.25 million from THB  44.70 million in 1Q19, with Net profit margin at 6.02% in 1Q20 declined from 21.85% in 1Q19.    Details of the management discussion and

Osotspa Public Company Limited Q3’18 and 9M18 Management Discussion & Analysis 14 November 2018 Q3’18 and 9M18 Management Discussion & Analysis Page 1/7 Financial Highlights Q3’18 profit attributable